Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Détails
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_A5401C2FA2EC
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Périodique
PLOS ONE
ISSN
1932-6203
Statut éditorial
Publié
Date de publication
08/08/2022
Editeur⸱rice scientifique
Vranic Semir
Volume
17
Numéro
8
Pages
e0270571
Langue
anglais
Mots-clé
Multidisciplinary
Pubmed
Open Access
Oui
Financement(s)
Fondation Hoffmann-La Roche Ltd.
Création de la notice
10/11/2022 16:11
Dernière modification de la notice
23/01/2024 7:31
Données d'usage
